14 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

Merit Medical®

FDA UDI
Merit Medical Systems, Inc.·00884450226292·

CosmoLock Pedicle Screw System

FDA UDI
Kalitec Direct LLC·B07311K0112090·Tap, Cannulated, 7.5 mm

INFLATABLE PENILE PROSTHESIS

FDA Adverse Event
Injury ·AMERICAN MEDICAL SYSTEMS, INC.·Product code FHW·May 22, 1997

SCIMEDX PHASE II MPO IGG ANTIBODY EIA

FDA 510(k)
FDA Class 2 ·Immunology

SPECIALITY 42 UV (HEFILCON A) SOFT (HYDROPHILIC) CONTACT LENS FOR DAILY WEAR, SPECIALITY 42 UV TORIC (HEFILCON A) SOFT C

FDA 510(k)
FDA Class 2 ·Ophthalmic

ULTRA-THIN SDS BALLOON CATHETER

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC CORP.·Product code DQY·December 8, 2006

SUMMIT DUOFIX TAP SZ5 HI OFF

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code LPH·August 12, 2015

RECLAIM DIST REAMER EXTENSION

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC. 1818910·Product code LXH·March 19, 2013

PINNACLE MTL INS NEUT36IDX50OD

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL, LTD·Product code KWA·March 4, 2011

SYNCHROMED II

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code LKK·March 11, 2008

Arrow Pressure Injectable PICC Kit The Arrow International Pressure Injectable PICC is intended for short-term or long-term peripheral access to the central venous system for intravenous therapy and blood sampling

FDA Enforcement
Class II ·Terminated·Arrow International Inc·June 14, 2017

Belmont Rapid Infuser, a Fluid Management System, Model FMS2000.

FDA Enforcement
Class II ·Terminated·Belmont Instrument Corporation·October 24, 2012

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024